![BCTX - BriaCell Therapeutics Corp - Stock Price Chart]() |
Market Cap | 5.23M | EPS (ttm) | -8.25 |
P/E | - | EPS this Y | 41.56% |
Forward P/E | - | EPS next Y | 32.70% |
PEG | - | EPS past 5Y | 47.85% |
P/S | - | EPS next 5Y | 31.60% |
P/B | 0.41 | EPS Q/Q | -201.85% |
Dividend | - | Sales Q/Q | - |
Insider Own | 6.47% | Inst Own | 3.67% |
Insider Trans | 0.00% | Inst Trans | 0.52% |
Short Float | 3.32% | Earnings | Jun 16/a |
Analyst Recom | 1.00 | Target Price | 32.00 |
Avg Volume | 1.79M | 52W Range | 1.97 - 29.40 |
|
|
|
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada. |
|
 |
![IVP - Inspire Veterinary Partners Inc - Stock Price Chart]() |
Market Cap | 3.60M | EPS (ttm) | -30.70 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.23 | EPS next 5Y | - |
P/B | 1.11 | EPS Q/Q | 99.81% |
Dividend | - | Sales Q/Q | -24.68% |
Insider Own | 54.48% | Inst Own | 4.10% |
Insider Trans | 0.00% | Inst Trans | 0.21% |
Short Float | 1.93% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 77.06K | 52W Range | 0.90 - 401.50 |
|
|
|
Inspire Veterinary Partners, Inc. engages in the business of operating small animal general practice hospitals which serve all manner of companion pets, emphasizing canine, and feline breeds and including equine care. The firm is also involved in acquiring additional veterinary hospitals including general practice, mixed animal facilities, and critical and emergency care. The company was founded on December 2, 2020 and is headquartered in Virginia Beach, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Watters Timothy | Director | Dec 26 '24 | Sale | 0.18 | 467 | 85 | 0 | Dec 30 03:32 PM |
|
|
 |
![PFSA - Profusa Inc - Stock Price Chart]() |
Market Cap | - | EPS (ttm) | -1.57 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -58.30% |
Dividend | - | Sales Q/Q | - |
Insider Own | 80.66% | Inst Own | 7.12% |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 397.78K | 52W Range | 1.80 - 12.76 |
|
|
|
NorthView Acquisition Corp. is a blank check company, which intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Fred S. Knechtel and Jack E. Stover on April 19, 2021 and is headquartered in New York, NY. |
|
|  |
![SANW - S&W Seed Co - Stock Price Chart]() |
Market Cap | 3.82M | EPS (ttm) | -12.12 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -17.99% |
P/S | 0.10 | EPS next 5Y | - |
P/B | 0.14 | EPS Q/Q | 55.09% |
Dividend | - | Sales Q/Q | -47.87% |
Insider Own | 5.91% | Inst Own | 49.43% |
Insider Trans | 0.00% | Inst Trans | 43.78% |
Short Float | 2.03% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 25.00 |
Avg Volume | 40.49K | 52W Range | 1.99 - 11.60 |
|
|
|
S&W Seed Co. engages in the breeding, production, and sale of stevia and alfalfa seeds. The company was founded in 1980 and is headquartered in Longmont, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MFP PARTNERS LP | 10% Owner | Dec 19 '24 | Sale | 0.15 | 200,000 | 30,000 | 993,187 | Dec 23 10:24 AM |
|
|
 |
![SLP - Simulations Plus Inc - Stock Price Chart]() |
Market Cap | 260.84M | EPS (ttm) | -3.14 |
P/E | - | EPS this Y | 90.25% |
Forward P/E | 14.49 | EPS next Y | -11.24% |
PEG | - | EPS past 5Y | 0.62% |
P/S | 3.25 | EPS next 5Y | 22.32% |
P/B | 2.11 | EPS Q/Q | -2280.39% |
Dividend | 0.46% | Sales Q/Q | 9.81% |
Insider Own | 19.13% | Inst Own | 82.50% |
Insider Trans | -3.02% | Inst Trans | 6.85% |
Short Float | 9.59% | Earnings | Jul 14/a |
Analyst Recom | 1.67 | Target Price | 25.33 |
Avg Volume | 436.52K | 52W Range | 16.72 - 44.33 |
|
|
Today | Downgrade |
KeyBanc Capital Markets |
Overweight → Sector Weight |
|
|
|
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WOLTOSZ WALTER S | Director | Jul 01 '25 | Sale | 18.33 | 20,000 | 366,623 | 3,304,157 | Jul 02 04:24 PM | VIRGINIA EVANS WOLTOSZ & WALTE | Director | Jul 01 '25 | Proposed Sale | 17.45 | 60,000 | 1,047,000 | | Jul 01 04:34 PM | WOLTOSZ WALTER S | Director | Jun 02 '25 | Sale | 27.15 | 20,000 | 543,074 | 3,324,157 | Jun 03 04:57 PM | WOLTOSZ WALTER S | Director | May 01 '25 | Sale | 33.51 | 20,000 | 670,150 | 3,344,157 | May 01 05:53 PM | WOLTOSZ WALTER S | Director | Apr 01 '25 | Sale | 24.09 | 20,000 | 481,786 | 3,363,371 | Apr 02 04:20 PM |
|
|
|  |
![MLEC - Moolec Science SA - Stock Price Chart]() |
Market Cap | 18.46M | EPS (ttm) | -2.15 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 2.36 | EPS next 5Y | - |
P/B | 6.58 | EPS Q/Q | -32.08% |
Dividend | - | Sales Q/Q | 948.32% |
Insider Own | 0.00% | Inst Own | 0.37% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.18% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 30.00 |
Avg Volume | 12.78K | 52W Range | 4.60 - 10.90 |
|
|
|
Moolec Science SA operates as a science-based ingredient company. It engages in the production of proteins through molecular farming technology. It also engages in the development of ingredients for food, pet food, animal feed, and dietary supplements. The company was founded by Gaston Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in Luxembourg. |
|
 |
![RANI - Rani Therapeutics Holdings Inc - Stock Price Chart]() |
Market Cap | 26.96M | EPS (ttm) | -0.98 |
P/E | - | EPS this Y | 17.14% |
Forward P/E | - | EPS next Y | 7.60% |
PEG | - | EPS past 5Y | 4.78% |
P/S | 22.47 | EPS next 5Y | 24.06% |
P/B | - | EPS Q/Q | 24.43% |
Dividend | - | Sales Q/Q | - |
Insider Own | 32.10% | Inst Own | 6.28% |
Insider Trans | 0.00% | Inst Trans | -4.65% |
Short Float | 14.18% | Earnings | May 13/a |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 1.49M | 52W Range | 0.46 - 4.19 |
|
|
|
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McKinley Kate | Chief Business Officer | Dec 13 '24 | Buy | 1.67 | 17,960 | 29,993 | 17,960 | Dec 16 06:00 PM | Imran Talat | Chief Executive Officer | Dec 09 '24 | Buy | 1.94 | 10,296 | 19,974 | 494,751 | Dec 10 01:12 PM | South Cone Investments Limited | 10% Owner | Oct 15 '24 | Sale | 2.65 | 3,829,360 | 10,141,674 | 8,302,194 | Oct 17 04:30 PM |
|
|
|  |
![FTRK - Fast Track Group - Stock Price Chart]() |
Market Cap | 12.06M | EPS (ttm) | -0.03 |
P/E | - | EPS this Y | 0.00% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 120.59 | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | -97.20% |
Insider Own | 41.20% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.44% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.96M | 52W Range | 0.62 - 9.69 |
|
|
|
Fast Track Group provides entertainment-focused event management and marketing services in Singapore, Malaysia, and Thailand. The company operates through Live Entertainment and Agency segments. It engages in the organization and management of live events and concerts by renowned international artistes. The company also provides agency services for artiste endorsements, including artiste broker and supply services to clients. In addition, it offers media planning, public relations management, technical production planning, celebrity sourcing, celebrity engagement consultancy, and event manpower support services. The company was incorporated in 2012 and is based in Singapore. |
|
 |
![SMX - SMX (Security Matters) Plc - Stock Price Chart]() |
Market Cap | 3.92M | EPS (ttm) | -3394.84 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.07 | EPS Q/Q | -64761.20% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.05% | Inst Own | 0.29% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.68% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 231.36K | 52W Range | 1.68 - 851.84 |
|
|
|
SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland. |
|
 |
![MASK - 3 E Network Technology Group Ltd - Stock Price Chart]() |
Market Cap | 14.78M | EPS (ttm) | 0.17 |
P/E | 7.68 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 3.13 | EPS next 5Y | - |
P/B | 3.91 | EPS Q/Q | 56.25% |
Dividend | - | Sales Q/Q | 5.25% |
Insider Own | - | Inst Own | 0.89% |
Insider Trans | - | Inst Trans | 1.35% |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 69.04K | 52W Range | 1.40 - 4.19 |
|
|
|
3 E Network Technology Group Ltd. operates as a holding company, which engages in the provision of business-to-business information technology business solutions. It offers business solutions to a variety of industries and sectors, including food establishments, real estate, exhibition and conferencing, and clean energy utilities. The company was founded on October 6, 2021 and is headquartered in Guangzhou, China. |
|
|